Background Polypharmacy (PP) and potentially inappropriate medications (PIM) are highly
prevalent in older adults with cancer. This study systematically reviews the associations of …

Background The expected 30-day mortality rate for patients treated with palliative radiation
is not established. The primary objective of this study is to define the proportion of patients …

Background Polypharmacy is an important issue in the care of older patients with cancer, as
it increases the risk of unfavorable outcomes. We estimated the prevalence of …

Polypharmacy is prevalent in older adults with cancer and may be advantageous for the
management of certain chronic disease states, but uncertainty exists regarding potential …

Purpose We examined prescription medication use and identified correlates of
polypharmacy—taking multiple medications—in adolescent and young adult cancer …

There are many additional considerations when treating older adults with cancer, especially
in the context of palliative care. Currently, radiation therapy is underutilised in some …

Polypharmacy is characterized by the simultaneous use of multiple medications, including
prescription drugs, over-the-counter drugs, and nutritional supplements. Polypharmacy is …

Most patients with lung cancer are smokers and are of advanced age. They are therefore at
high risk of having age-and lifestyle-related comorbidities. These comorbidities are subject …

Objective Polypharmacy has been associated with morbidity and mortality in patients with
cancer. Data about polypharmacy among patients with ovarian cancer are limited. The …

Results The total number of concomitant CYP3A4 inhibitors and substrates used was
significantly higher in patients with FN [mean: 2.1 (95% confidence interval (CI)= 1.5-2.9)] …